NGL FINECHEM
Back to Income Statement
|
NGL FINECHEM Last 5 Year Operating Profit History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Operating Profit (Excl OI) | ₹54 Cr | ₹35 Cr | ₹68 Cr | ₹80 Cr | ₹1,975,921 Cr |
What is the latest Operating Profit of NGL FINECHEM ?
| Year | Operating Profit |
|---|---|
| Mar2025 | ₹54 Cr |
| Mar2024 | ₹35 Cr |
| Mar2023 | ₹68 Cr |
| Mar2022 | ₹80 Cr |
| Mar2021 | ₹1,975,921 Cr |
How is Operating Profit of NGL FINECHEM Trending?
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹54 Cr | 53.73 | |
| Mar2024 | ₹35 Cr | -48.74 | |
| Mar2023 | ₹68 Cr | -14.87 | |
| Mar2022 | ₹80 Cr | -100.00 | |
| Mar2021 | ₹1,975,921 Cr | - | |
Compare Operating Profit of peers of NGL FINECHEM
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NGL FINECHEM | ₹895.9 Cr | 1.3% | 5.9% | -18.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹416,728.0 Cr | -1.3% | -3.9% | -5.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹172,248.0 Cr | -2.3% | 0.9% | 12.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹133,627.0 Cr | 0.3% | 3.9% | 19.2% | Stock Analytics | |
| CIPLA | ₹118,423.0 Cr | -4.2% | -3.1% | -1.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,462.0 Cr | -3.2% | -4.5% | -11.8% | Stock Analytics | |
NGL FINECHEM Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NGL FINECHEM | 1.3% |
5.9% |
-18.4% |
| SENSEX | -1.8% |
-0.6% |
7.3% |
You may also like the below Video Courses